تحميل...
Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold
Cannabinoid type 2 (CB(2)) receptor has been implicated in several diseases and conditions, however no CB(2) receptor selective drugs have made it to market. The aim of this study was to develop fluorescent ligands as CB(2) receptor tools, to enable an increased understanding of CB(2) receptor expre...
محفوظ في:
| الحاوية / القاعدة: | Medchemcomm |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Royal Society of Chemistry
2018
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6301273/ https://ncbi.nlm.nih.gov/pubmed/30647881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c8md00448j |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|